05-24103. Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of New Animal Drug Applications  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is withdrawing approval of 15 new animal drug applications (NADAs) because the products are no longer manufactured or marketed. In a final rule published elsewhere in this issue of the Federal Register, FDA is amending the animal drug regulations to remove portions reflecting approval of the NADAs.

    DATES:

    Withdrawal of approval is effective December 27, 2005.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Pamela K. Esposito, Center for Veterinary Medicine (HFV-210), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-276-9067, e-mail: pesposit@cvm.fda.gov.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    The following sponsors have requested that FDA withdraw approval of the 15 NADAs listed in table 1 of this document because the products are no longer manufactured or marketed:

    Table 1.

    SponsorNADA Number, Product (Drug)21 CFR Section Affected (Sponsor Drug Labeler Code)
    Bioproducts, Inc., 320 Springside Dr., Suite 300, Fairlawn, OH 44333-2435NADA 119-063, Pyrantel Tartrate Ton Pack (pyrantel tartrate)558.485 (051359)
    Farmland Industries, Inc., Kansas City, MO 64116NADA 138-656, BN Wormer—19.2 BANMINTH Premix (pyrantel tartrate)558.485 (021676)
    I.M.S. Inc., 13619 Industrial Rd., Omaha, NE 68137NADA 129-395, HYGROMIX 0.6 Premix (hygromycin B)558.274 (050639)
    NADA 129-646, TYLAN 10 Sulfa-G (tylosin, sulfamethazine)558.630 (050639)
    NADA 136-601, Swine Guard-BN (pyrantel tartrate)558.485 (050639)
    J. & R. Specialty Supply Co., 310 Second Ave., SW,, P.O. Box 506, Waseca, MN 56093NADA 96-780, TYLAN 10; TYLAN 40 (tylosin)n/a (049768)
    Kerber Milling Co., Box 152, 1817 E. Main St., Emmetsburg, IA 50536NADA 98-687, Hy-Test Hy-Boost TY 5 Medicated (tylosin)558.625 (029341)
    M & M Livestock Products Co., Eagle Grove, IA 50533NADA 96-837, M & M Tylosin Premix (tylosin)558.625 (026282)
    Nutra-Blend Corp., P.O. Box 485, Neosho, MO 64850NADA 129-161, Nutra-Blend TYLAN 10 Sulfa Premix (tylosin, sulfamethazine)558.630 (050568)
    NADA 136-384, Swine Wormer-BN BANMINTH (pyrantel tartrate)558.485 (050568)
    South St. Paul Feeds, Inc., 500 Farwell Ave., South St. Paul, MN 55075NADA 136-369, Custom Ban Wormer 9.6 (pyrantel tartrate)558.485 (001800)
    Stockton Hay & Grain Co.NADA 49-462, Rainbrook Broiler Premix No. 1 (ampolium, arsanilic acid, ethopabate, penicillin G procaine, streptomycin)n/a (036541)
    NADA 91-646, Rainbow Broiler Base Concentrate (ampolium, bacitracin zinc, ethopabate)n/a (036541)
    NADA 91-647, Broiler Base Concentrate (ampolium, chlortetracyline, ethopabate)n/a (036541)
    Triple “F”, Inc., 10104 Douglas Ave., Des Moines, IA 50322NADA 131-146, FLAVOMYCIN 0.4 (bambermycins)558.95 (011490)

    Therefore, under authority delegated to the Commissioner of Food and Drugs (21 CFR 5.10), redelegated to the Center for Veterinary Medicine (21 CFR 5.84), and in accordance with § 514.115 Withdrawal of approval of applications (21 CFR 514.115), notice is given that approval of NADAs 49-462, 91-646, 91-647, 96-780, 96-837, 98-687, 119-063, 129-161, 129-395, 129-646, 131-146, 136-369, 136-384, 136-601, 138-656, and all supplements and Start Printed Page 74823amendments thereto, is hereby withdrawn, effective December 27, 2005.

    In a final rule published elsewhere in this issue of the Federal Register, FDA is amending the animal drug regulations to reflect the withdrawal of approval of these NADAs.

    Start Signature

    Dated: December 7, 2005.

    Stephen F. Sundlof,

    Director, Center for Veterinary Medicine.

    End Signature End Supplemental Information

    [FR Doc. 05-24103 Filed 12-15-05; 8:45 am]

    BILLING CODE 4160-01-S

Document Information

Effective Date:
12/27/2005
Published:
12/16/2005
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
05-24103
Dates:
Withdrawal of approval is effective December 27, 2005.
Pages:
74822-74823 (2 pages)
Docket Numbers:
Docket No. 2005N-0150
PDF File:
05-24103.pdf